APPLICATION
ANDA213708
TYPE
ANDA
ORIGINAL APPROVAL
2024-11-20
LATEST ACTION
2024-11-20
ROUTE
INTRAMUSCULAR, INTRAOCULAR, INTRAVENOUS, SUBCUTANEOUS, INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
EPINEPHRINEPrescription
EPINEPHRINE 1MG/ML (1MG/ML) · SOLUTION · INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS
Approval history
2024-11-20UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.